Evidence map›Paper›PMID 24027280›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

P2X receptor intermediate activation states have altered nucleotide selectivity.

Liam E Browne, R Alan North

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Optical control of trimeric P2X receptors and acid-sensing ion channels.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  16. Exploring the ATP-binding site of P2X receptors.Frontiers in cellular neuroscience · 2013
    Review
  17. ATP P2X3 receptors and neuronal sensitization.Frontiers in cellular neuroscience · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Liam E BrowneFaculties of Medical and Human Sciences, and Life Sciences, University of Manchester, Manchester, M13 9PT, United Kingdom.
R Alan North
University of Manchester · GB

Funding

Wellcome TrustWellcome Trust 093140/Z/10/Z
6 · The paper itself

Abstract

Purinergic P2X receptors are widely distributed in the nervous system and are known to play roles in primary afferent transmission and central respiratory regulation. They are trimeric membrane proteins, with the extracellular domain that provides three intersubunit ATP binding sites. We expressed the rat P2X7 receptor in human embryonic kidney cells and measured membrane currents before and after photo-affinity labeling with the agonist 2'(3')-O-(4-benzoylbenzoyl)-ATP (BzATP). After tethering BzATP with ultraviolet light, a persistent current remained after washing out the agonist. Additional current could now be elicited by other nucleotides (CTP and ADP) that are not normally effective as P2X receptor agonists. Similar results were obtained at P2X2 receptors even without previous agonist tethering: exposure to low concentrations of ATP caused the receptor to become sensitive to activation by CTP and ADP. The results show that ATP binding to the first of the three binding sites causes a conformational change to an intermediate closed state that shows increased effectiveness of pyrimidine and diphosphate nucleotide analogs.

Indexed as

Adenosine DiphosphateAdenosine TriphosphateAnimalsGreen Fluorescent ProteinsHEK293 CellsHumansNucleotidesPatch-Clamp TechniquesPlatelet Aggregation InhibitorsPurinergic P2X Receptor AntagonistsPyridinesRatsReceptors, Purinergic P2X2Receptors, Purinergic P2X7TetrazolesTime Factors3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine DiphosphateAdenosine Triphosphateenhanced green fluorescent proteinGreen Fluorescent ProteinsNucleotidesPlatelet Aggregation InhibitorsPurinergic P2X Receptor AntagonistsPyridinesReceptors, Purinergic P2X2Receptors, Purinergic P2X7TetrazolesUridine TriphosphateZinc

Identifiers

PMID24027280
PMCPMC3771025
OpenAlexW2054921672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.